hasPharmacogenomicAssociation
P92924
predicate
Indicates that there is a documented relationship between a genetic variant and a drug’s response, efficacy, or toxicity.
All labels observed (3)
| Label | Occurrences |
|---|---|
| hasPharmacogenomicAssociation canonical | 4 |
| associatedWithBiomarker | 3 |
| polymorphismsAffect | 2 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasPharmacogenomicAssociation
Generated description
Indicates that there is a documented relationship between a genetic variant and a drug’s response, efficacy, or toxicity.
Sample triples (9)
| Subject | Object |
|---|---|
| warfarin | CYP2C9 polymorphisms ⓘ |
| warfarin | VKORC1 polymorphisms ⓘ |
| Lynparza | BRCA1 mutation via predicate surface "associatedWithBiomarker" ⓘ |
| Lynparza | BRCA2 mutation via predicate surface "associatedWithBiomarker" ⓘ |
| HGNC:28350 | C9orf72 repeat expansion testing via predicate surface "associatedWithBiomarker" ⓘ |
| CYP2C9 | enzyme activity via predicate surface "polymorphismsAffect" ⓘ |
| CYP2C9 | warfarin dose requirements via predicate surface "polymorphismsAffect" ⓘ |
| carbamazepine | HLA-B*1502 allele NERFINISHED ⓘ |
| carbamazepine | HLA-A*3101 allele NERFINISHED ⓘ |